In 1985, B.S., Biology, Sichuan University, Chengdu, China; In 1996, PhD, Molecular Biology, University of Tennessee, Knoxville, USA; In 1996-1997, Postdoctoral fellow, Neurology, Medical School of Johns Hopkins University, Baltimore, USA.
Active member in American Association for Cancer Research, Standing committee member of Chinese Anti-cancer Association-Biomarker Subcommittee, Member, Chinese Society for Clinical Oncology; Editorial Board Member in Thoracic Cancer and The Chinese Journal of Lung Cancer; Reviewer for Beijing Science and Technology Awards, Cancer Letters, DNA and Cell Biology, PloS One etc.
Research Interests and Achievements:
Focus on 1) tumor microenvironment for tumorigenesis and progression, 2) Tumor biomarker discovery for clinical applications. We are dedicated to investigate how tumor immune-microenvironment regulates tumor initiation and progression especially how tumor induces immunosuppressive microenvironment to promote tumor development. Meanwhile, we have been pursuing to identify clinically valuable biomarkers for tumor diagnosis and directing targeted and individualized therapies. Accordingly, we have published more than 30 related articles and been granted three patents including the recent one entitled Combined IGFBP2 and IGFBP2 autoantibody-based tumor diagnosis and its application.